Your Comments On...
MedImmune Asks For Right to Sue
A lawyer for MedImmune Inc. asked the Supreme Court yesterday to let the company sue to overturn a patent owned by Genentech Inc. on a component of MedImmune's blockbuster drug Synagis, even though MedImmune is paying royalties to use it.
By Charles Lane
E-Mail This Page
© 2006 The Washington Post Company